The past few years have been really hard on entire humanity. Scientists all around the globe were finding a cure for COVID-19, and to some extent, they become successful. In 2021 and 2022, widespread COVID-19 vaccination campaigns were successfully completed in many nations. However, during that same period, a new medical condition named long COVID entered our world, unfurling like a dark carpet. 

In this small guide, let’s understand Long COVID and how different forms of Apheresis serve as a potential best treatment. Moreover, let’s know how the LCA community is trying to decode the best long COVID treatment mystery by studying different forms of Apheresis treatment outcomes or data. 

What exactly is long COVID?  

Long COVID, also known as PASC (Post-Acute Sequelae of SARS-CoV-2 infection), is a medical condition where an individual experiences the set of symptoms for COVID-19 even after recovering from the acute illness COVID period (the phase where it is at its peak). The exact cause of long COVID is unknown, and its symptoms may vary from person to person. Still, the most common one includes fatigue, shortness of breath, chest pain, and joint pain.

Different forms of Apheresis as Potential Treatment for Long COVID: 

Apheresis is a medical procedure where professionals separate blood components and remove certain elements to treat long COVID. Apheresis treatments are used in the clinics of Germany, Cyprus, and Switzerland to treat various health conditions. And as per many healthcare professionals, Apheresis can also be used to treat long COVID as well. There are many forms or distant techniques of Apheresis that can be used for long COVID treatment. Some of them are as follows: 

•   Plasmapheresis 
•   Plateletpheresis 
•   Leukapheresis 
•  Erythrocytapheresis
• Photopheresis
•  Immunoadsorption 

LCA Community: Making Global Survey on Apheresis Treatments 

LCA community stands for ‘Long COVID Apheresis’ Community. We’re a group of patients, medical professionals, and individuals having indirect links with long COVID. LCA community aims to collect data from patients around the globe who’ve treated their long-term COVID through a particular form of Apheresis treatment. Not only collect, we study the different forms of Apheresis treatment outcomes. Since there are many forms of Apheresis treatments, there is often a debate about which form is the best to treat long COVID. That’s why the LCA community takes responsibility for ending this debate by surveying to find which form of Apheresis has the best success rate in treating Long COVID. 

Takeaway: 

If you’re one of the individuals who have successfully recovered through one of the Apheresis forms, LCA Community would like you to do a favor by sharing your whole treatment process reports with us. Healthcare professionals and clinicians are also welcome to share reliable research papers and reports indicating the success rate of different forms of Apheresis. The LCA community aims to revolutionize the long COVID treatment sector by conducting a global survey. Visit our website to submit your reports now!